Dundee biotech PhaSER wins $2.7M Gates grant for infectious disease drugs
Scottish biotech PhaSER Biomedical has won a $2.7M (£2m) grant from the Gates Foundation to help find new drugs for diseases such as TB and malaria. The company announced the award in a statement this morning.
Read the full story on The Next Web.